Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

995 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective open label 2-8 year extension of the randomised controlled ICON trial on the long-term efficacy and safety of occipital nerve stimulation in medically intractable chronic cluster headache.
Brandt RB, Wilbrink LA, de Coo IF, Haan J, Mulleners WM, Huygen FJPM, van Zwet EW, Ferrari MD, Fronczek R; ICON study group. Brandt RB, et al. Among authors: haan j. EBioMedicine. 2023 Dec;98:104895. doi: 10.1016/j.ebiom.2023.104895. Epub 2023 Nov 25. EBioMedicine. 2023. PMID: 38007947 Free PMC article. Clinical Trial.
Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial.
Wilbrink LA, Teernstra OP, Haan J, van Zwet EW, Evers SM, Spincemaille GH, Veltink PH, Mulleners W, Brand R, Huygen FJ, Jensen RH, Paemeleire K, Goadsby PJ, Visser-Vandewalle V, Ferrari MD. Wilbrink LA, et al. Among authors: haan j. Cephalalgia. 2013 Nov;33(15):1238-47. doi: 10.1177/0333102413490351. Epub 2013 May 29. Cephalalgia. 2013. PMID: 23720502 Clinical Trial.
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial.
Wilbrink LA, de Coo IF, Doesborg PGG, Mulleners WM, Teernstra OPM, Bartels EC, Burger K, Wille F, van Dongen RTM, Kurt E, Spincemaille GH, Haan J, van Zwet EW, Huygen FJPM, Ferrari MD; ICON study group. Wilbrink LA, et al. Among authors: haan j. Lancet Neurol. 2021 Jul;20(7):515-525. doi: 10.1016/S1474-4422(21)00101-0. Lancet Neurol. 2021. PMID: 34146510 Clinical Trial.
Chronic cluster headache: a review.
Favier I, Haan J, Ferrari MD. Favier I, et al. Among authors: haan j. J Headache Pain. 2005 Feb;6(1):3-9. doi: 10.1007/s10194-005-0142-9. Epub 2005 Jan 25. J Headache Pain. 2005. PMID: 16362185 Free PMC article. Review.
Genetic factors in cluster headache.
Vliet JA, Ferrari MD, Haan J. Vliet JA, et al. Among authors: haan j. Expert Rev Neurother. 2003 May;3(3):301-6. doi: 10.1586/14737175.3.3.301. Expert Rev Neurother. 2003. PMID: 19810897
Evaluation of the new ICHD-III beta cluster headache criteria.
de Coo IF, Wilbrink LA, Haan J, Ferrari MD, Terwindt GM. de Coo IF, et al. Among authors: haan j. Cephalalgia. 2016 May;36(6):547-51. doi: 10.1177/0333102415607856. Epub 2015 Sep 22. Cephalalgia. 2016. PMID: 26395893
Cluster headache and depression.
Louter MA, Wilbrink LA, Haan J, van Zwet EW, van Oosterhout WP, Zitman FG, Ferrari MD, Terwindt GM. Louter MA, et al. Among authors: haan j. Neurology. 2016 Nov 1;87(18):1899-1906. doi: 10.1212/WNL.0000000000003282. Epub 2016 Sep 30. Neurology. 2016. PMID: 27694264
Allodynia in cluster headache.
Wilbrink LA, Louter MA, Teernstra OPM, van Zwet EW, Huygen FJPM, Haan J, Ferrari MD, Terwindt GM. Wilbrink LA, et al. Among authors: haan j. Pain. 2017 Jun;158(6):1113-1117. doi: 10.1097/j.pain.0000000000000891. Pain. 2017. PMID: 28267062
995 results